Business Description
GeneOne Life Science Inc
ISIN : KR7011000007
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | -0.34 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -0.83 | |||||
Beneish M-Score | -4.94 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.1 | |||||
3-Year EBITDA Growth Rate | -64 | |||||
3-Year EPS without NRI Growth Rate | -51.2 | |||||
3-Year FCF Growth Rate | 7.2 | |||||
3-Year Book Growth Rate | 0.1 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.06 | |||||
9-Day RSI | 33.53 | |||||
14-Day RSI | 38.85 | |||||
6-1 Month Momentum % | 67.26 | |||||
12-1 Month Momentum % | 10.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.25 | |||||
Quick Ratio | 0.57 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 121.89 | |||||
Days Sales Outstanding | 66.03 | |||||
Days Payable | 78.5 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.1 | |||||
Shareholder Yield % | -1.72 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -15.89 | |||||
Operating Margin % | -112.48 | |||||
Net Margin % | -180.49 | |||||
FCF Margin % | -50.72 | |||||
ROE % | -56.39 | |||||
ROA % | -43.66 | |||||
ROIC % | -30.97 | |||||
3-Year ROIIC % | -40.14 | |||||
ROC (Joel Greenblatt) % | -54.11 | |||||
ROCE % | -50 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.82 | |||||
PB Ratio | 1.9 | |||||
Price-to-Tangible-Book | 1.93 | |||||
EV-to-EBIT | -2.96 | |||||
EV-to-EBITDA | -3.91 | |||||
EV-to-Revenue | 5.25 | |||||
EV-to-FCF | -10.35 | |||||
Price-to-Median-PS-Value | 0.93 | |||||
Earnings Yield (Greenblatt) % | -33.78 | |||||
FCF Yield % | -10.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
GeneOne Life Science Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 40,802.415 | ||
EPS (TTM) (â‚©) | -940 | ||
Beta | 0.64 | ||
Volatility % | 65.03 | ||
14-Day RSI | 38.85 | ||
14-Day ATR (â‚©) | 238.639605 | ||
20-Day SMA (â‚©) | 3014.5 | ||
12-1 Month Momentum % | 10.2 | ||
52-Week Range (â‚©) | 1996 - 4735 | ||
Shares Outstanding (Mil) | 79.83 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
GeneOne Life Science Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
GeneOne Life Science Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
GeneOne Life Science Inc Frequently Asked Questions
What is GeneOne Life Science Inc(XKRX:011000)'s stock price today?
When is next earnings date of GeneOne Life Science Inc(XKRX:011000)?
Does GeneOne Life Science Inc(XKRX:011000) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |